NVO Kronos AI forecast
A 30-trading-day price forecast for Novo Nordisk A/S (NVO) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Novo Nordisk A/S at $43.33 on 2026-12-08, +12.1% from the last close of $38.67 on 2026-10-27. Eight out of ten sampled paths end between $41.84 and $45.04, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of NVO
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $39.06 | $37.45 | $39.49 |
| 2026-11-10 | $40.43 | $38.76 | $41.99 |
| 2026-11-17 | $42.48 | $41.30 | $43.08 |
| 2026-11-24 | $42.76 | $41.35 | $43.67 |
| 2026-12-01 | $43.17 | $40.87 | $44.65 |
| 2026-12-08 | $43.33 | $41.84 | $45.04 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for NVO?
- Kronos AI's median forecast for NVO is $43.33 in 30 trading days, +12.1% from the last close, with a 10–90% range of $41.84 to $45.04.
- Is the NVO Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC